Medicinal Products

Mavenclad

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Mavenclad
Active Substance kladribin
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01BB04
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Vodič zdravstvene radnike, verzija 2
Educational materials
for patients / caregivers
Vodič za bolesnike, verzija 2

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o riziku od ozbiljnog oštećenja jetre i novim preporukama o praćenju funkcije jetre za lijek Mavenclad (kladribin) 14.02.2022 Merck d.o.o.
Back